All In MedTech

Device Trial Radar · NCT05143541

Use of a New Stapling Device in General Thoracic Surgery

Last checked: Nov 20, 2026Latest source record: Dec 29, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

80

Actual

Start

Mar 1, 2021

Primary completion

Sep 30, 2021

Study completion Sep 30, 2021

Sponsor

Lead sponsor
Lexington Medical Inc.Not on our public-company list
Sponsor type
Industry
First posted
Dec 3, 2021

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this study was to test the safety and efficacy of this stapler in our general thoracic surgery practice.

Conditions

  • Thoracic Cancer

Interventions

  • AEON EndostaplerDevice

    Surgery with AEON Endostapler

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Product MalfunctionTime frame: Within surgery, up to 8 hours
  2. Number of Participants With Intraoperative Staple Line BleedingTime frame: Within surgery, up to 8 hours
  3. Number of Participants With Reported Device-related Adverse EventsTime frame: Within 30-day post-operative period

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Kantonsspital St. Gallen

    Sankt Gallen, Switzerland

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.